The Food and Drug Administration gave FluMist nasal spray the green light for self- or caregiver-home use on September 20, ...

Just a few months after starting clinical trials of its nasal spray vaccine for COVID-19, US biotech Altimmune is abandoning the project, saying that it generated weaker than expected immune ...

British pharmaceutical company AstraZeneca (AZ) has developed a nasal spray flu vaccine named "FluMist." It was initially approved for medical institutions in 2003, and in October of last year ...

With some wondering when Western nations would catch up, last week Oxford researchers revealed the results of a phase 1 trial for a simple nasal spray using the AstraZeneca vaccine. However ...

Here’s how it would work: A nasal mRNA vaccine would be taken as a spray through the nose, coating the nasal passages. The cells in the nasal lining would use the vaccine’s instructions to ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Emergent Biosolutions (EBS – Research Report), with a ...

Several mucosal vaccine candidates are being explored in pre-clinical and clinical trials. Results just published on a nasal booster vaccine in mice showed that robust mucosal immune responses were ...

Injectable vaccines are commonly used in clinical settings, ensuring higher adoption. However, the nasal spray segment is expected to grow rapidly. These vaccines offer ease of administration and ...